Stock ISIS PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News ISIS Pharmaceuticals, Inc. Nasdaq

Equities

US4643301090

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Ionis announces webcast to report HALOS study results for ION582 in Angelman syndrome
PR
Stifel Adjusts Ionis Pharmaceuticals Price Target to $53 From $50, Maintains Hold Rating
MT
Ionis announces olezarsen FCS New Drug Application accepted for Priority Review and enrollment in Phase 3 sHTG program completed
AQ
Ionis Pharmaceuticals' Shares Rise After FDA Accepts Metabolic Disorder Drug Candidate for Priority Review
MT
Ionis Pharmaceuticals Says FDA Accepts Metabolic Disorder Drug Candidate for Priority Review
MT
Ionis Pharmaceuticals, Inc. Announces olezarsen FCS New Drug Application Accepted for Priority Review and Enrollment in Phase 3 sHTG Program Completed
CI
ANALYST RECOMMENDATIONS : Home Depot, Apple, Micron Technology, Anglo American, United Utilities...
Our Logo
Ionis Pharmaceuticals Insider Sold Shares Worth $644,640, According to a Recent SEC Filing
MT
Transcript : Ionis Pharmaceuticals, Inc. Presents at TD Cowen?s Genetic Medicines & RNA Summit, Jun-20-2024 03:30 PM
Ionis Pharmaceuticals Says Otsuka Obtains Rights for Investigational Hereditary Angioedema Treatment in Asia Pacific
MT
Ionis to present at TD Cowen Genetic Medicines and RNA Summit
AQ
Ionis announces expanded licensing agreement with Otsuka in Asia Pacific for investigational medicine donidalorsen in hereditary angioedema
PR
Ionis Pharmaceuticals, Inc. Announces Expand Licensing Agreement with Otsuka Pharmaceutical Co., Ltd
CI
Ionis to present at TD Cowen Genetic Medicines & RNA Summit
PR
Investors need more time to assess Fed comments
Our Logo
Bernstein Upgrades Ionis Pharmaceuticals to Market Perform From Underperform, Adjusts Price Target to $44 From $37
MT
ANALYST RECOMMENDATIONS : Adobe, Bank of America, Boeing, Nvidia, Wise...
Our Logo
Transcript : Ionis Pharmaceuticals, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-10-2024 through Jun-13-2024
Transcript : Ionis Pharmaceuticals, Inc. - Special Call
Ionis Pharmaceuticals : Login Information
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. IONS Stock
  4. Stock
  5. News ISIS Pharmaceuticals, Inc.